Skip to content

Optease Vena Cava Filter and Optease Retrieval Cathteter

by Cordis, A Johnson & Johnson Co.

510(k) K140286

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK140286 Date7 Mar 2014ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTK
Device Class
Class II
Regulation
21 CFR Part 870.3375
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The OptEase Vena Cava Filter and Retrieval Catheter is an intravascular filter designed for placement within the inferior vena cava to prevent pulmonary embolism by capturing venous thrombi. It is classified as a retrievable device, allowing for removal once the risk of embolism has resolved, typically within up to 12 days post-implantation. The filter is engineered to minimize complications associated with long-term placement while providing temporary protection for patients at risk of deep vein thrombosis.

This device is supplied as a kit, including a 90 cm catheter for delivery through multiple venous access sites, such as the femoral, jugular, or antecubital veins. It is intended for single-use and requires sterile handling in a clinical setting, such as a catheterization lab or operating room. The OptEase system has received FDA 510(k) clearance under the Special 510(k) pathway, adhering to regulatory standards for cardiovascular devices classified under DTK (Device Type Code). No additional regulatory markings or MRI safety classifications are specified.

Other devices from Cordis Corp., A Johnson & Johnson Co.

See all devices from Cordis Corp., A Johnson & Johnson Co. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the OptEase Vena Cava Filter designed to do?

    The OptEase Vena Cava Filter is an intravascular device placed within the inferior vena cava to prevent pulmonary embolism by trapping venous thrombi. It is specifically engineered as a retrievable filter, allowing for removal once the patient’s risk of embolism has resolved, typically within up to 12 days after implantation. This design minimizes complications associated with long-term placement while providing temporary protection for patients at risk of deep vein thrombosis.

  • How is the OptEase Vena Cava Filter supplied, and what access sites can it use?

    The OptEase Vena Cava Filter is supplied as a complete kit, including a 90 cm catheter. This catheter is designed for delivery through multiple venous access sites, such as the femoral, jugular, or antecubital veins. The kit ensures all necessary components are available for immediate use in a clinical setting like a catheterization lab or operating room.

  • Is the OptEase Vena Cava Filter intended for single-use or reuse?

    The OptEase Vena Cava Filter is intended for single-use only. This design ensures sterility and safety, as it requires sterile handling in a controlled clinical environment. Reuse is not recommended or supported by the manufacturer to maintain efficacy and prevent contamination.

  • What are the key considerations for storage of the OptEase Vena Cava Filter kit?

    The OptEase Vena Cava Filter kit must be stored in a manner that preserves its sterility and integrity. It should be kept in its original packaging, protected from moisture, dust, and extreme temperatures. The manufacturer’s instructions for storage conditions should be followed to ensure the device remains functional and safe for use when needed.

  • What regulatory pathway does the OptEase Vena Cava Filter follow?

    The OptEase Vena Cava Filter has received FDA 510(k) clearance under the Special 510(k) pathway. This pathway is used for devices that are substantially equivalent to a predicate device already on the market. The clearance was granted by the FDA’s Cardiovascular (CV) advisory committee, adhering to regulatory standards for cardiovascular devices classified under Device Type Code (DTK).